BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $1.80 and last traded at $1.50, with a volume of 79022 shares changing hands. The stock had previously closed at $1.56.
BioRestorative Therapies Stock Performance
The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -1.46 and a beta of 102.36. The firm’s 50 day moving average is $1.64 and its 200-day moving average is $1.58.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- 3 Monster Growth Stocks to Buy Now
- Intel: Is Now the Time to Be Brave?
- How to Buy Cheap Stocks Step by Step
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- There Are Different Types of Stock To Invest In
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
